Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

K Rothman

Showing results (81-90 of 98) with videos related to

Pageof 10
Sort By:
American Journal of Respiratory and Critical Care Medicine|March 13, 2025
Positioning Imatinib for Pulmonary Arterial Hypertension: A Dose-Finding Phase 2 StudyAlexander M K Rothman, Sofia Villar, Jennifer Middleton, et al.
JACC. Cardiovascular Imaging|November 22, 2020
Right Ventricular Adaptation Assessed Using Cardiac Magnetic Resonance Predicts Survival in Pulmonary Arterial HypertensionZe Ming Goh, Samer Alabed, Yousef Shahin, et al.
European Heart Journal. Digital Health|January 30, 2023
Machine learning cardiac-MRI features predict mortality in newly diagnosed pulmonary arterial hypertensionSamer Alabed, Johanna Uthoff, Shuo Zhou, et al.
Heart (British Cardiac Society)|May 5, 2022
Right ventricular remodelling in pulmonary arterial hypertension predicts treatment responseZe Ming Goh, Nithin Balasubramanian, Samer Alabed, et al.
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation|September 11, 2024
The spectrum of systemic sclerosis-associated pulmonary hypertension: Insights from the ASPIRE registryHoward Smith, A A Roger Thompson, Mohammed Akil, et al.
ERJ Open Research|March 25, 2026
Diffusing capacity of the lung for carbon monoxide, transfer coefficient of the lung for carbon monoxide and forced vital capacity/diffusing capacity of the lung for carbon monoxide in suspected systemic sclerosis-associated pulmonary hypertension: insights from the ASPIRE registryHoward Smith, A A Roger Thompson, Mohammed Akil, et al.
JACC. Cardiovascular Interventions|April 25, 2020
Intravascular Ultrasound Pulmonary Artery Denervation to Treat Pulmonary Arterial Hypertension (TROPHY1): Multicenter, Early Feasibility StudyAlexander M K Rothman, Jean-Luc Vachiery, Luke S Howard, et al.
Annals of the American Thoracic Society|September 14, 2020
Maximal Exercise Testing Using the Incremental Shuttle Walking Test Can Be Used to Risk-Stratify Patients with Pulmonary Arterial HypertensionRobert A Lewis, Catherine G Billings, Judith A Hurdman, et al.
The European Respiratory Journal|February 1, 2024
Systematic pulmonary embolism follow-up increases diagnostic rates of chronic thromboembolic pulmonary hypertension and identifies less severe disease: results from the ASPIRE RegistryCharlotte Durrington, Judith A Hurdman, Charlie A Elliot, et al.
Frontiers in Cardiovascular Medicine|April 11, 2022
Imaging and Risk Stratification in Pulmonary Arterial Hypertension: Time to Include Right Ventricular AssessmentFaisal Alandejani, Abdul Hameed, Euan Tubman, et al.
Pageof 10

Showing results (81-90 of 98) with videos related to

Sort By:
Pageof 10
American Journal of Respiratory and Critical Care Medicine|March 13, 2025
Positioning Imatinib for Pulmonary Arterial Hypertension: A Dose-Finding Phase 2 StudyAlexander M K Rothman, Sofia Villar, Jennifer Middleton, et al.
JACC. Cardiovascular Imaging|November 22, 2020
Right Ventricular Adaptation Assessed Using Cardiac Magnetic Resonance Predicts Survival in Pulmonary Arterial HypertensionZe Ming Goh, Samer Alabed, Yousef Shahin, et al.
European Heart Journal. Digital Health|January 30, 2023
Machine learning cardiac-MRI features predict mortality in newly diagnosed pulmonary arterial hypertensionSamer Alabed, Johanna Uthoff, Shuo Zhou, et al.
Heart (British Cardiac Society)|May 5, 2022
Right ventricular remodelling in pulmonary arterial hypertension predicts treatment responseZe Ming Goh, Nithin Balasubramanian, Samer Alabed, et al.
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation|September 11, 2024
The spectrum of systemic sclerosis-associated pulmonary hypertension: Insights from the ASPIRE registryHoward Smith, A A Roger Thompson, Mohammed Akil, et al.
ERJ Open Research|March 25, 2026
Diffusing capacity of the lung for carbon monoxide, transfer coefficient of the lung for carbon monoxide and forced vital capacity/diffusing capacity of the lung for carbon monoxide in suspected systemic sclerosis-associated pulmonary hypertension: insights from the ASPIRE registryHoward Smith, A A Roger Thompson, Mohammed Akil, et al.
JACC. Cardiovascular Interventions|April 25, 2020
Intravascular Ultrasound Pulmonary Artery Denervation to Treat Pulmonary Arterial Hypertension (TROPHY1): Multicenter, Early Feasibility StudyAlexander M K Rothman, Jean-Luc Vachiery, Luke S Howard, et al.
Annals of the American Thoracic Society|September 14, 2020
Maximal Exercise Testing Using the Incremental Shuttle Walking Test Can Be Used to Risk-Stratify Patients with Pulmonary Arterial HypertensionRobert A Lewis, Catherine G Billings, Judith A Hurdman, et al.
The European Respiratory Journal|February 1, 2024
Systematic pulmonary embolism follow-up increases diagnostic rates of chronic thromboembolic pulmonary hypertension and identifies less severe disease: results from the ASPIRE RegistryCharlotte Durrington, Judith A Hurdman, Charlie A Elliot, et al.
Frontiers in Cardiovascular Medicine|April 11, 2022
Imaging and Risk Stratification in Pulmonary Arterial Hypertension: Time to Include Right Ventricular AssessmentFaisal Alandejani, Abdul Hameed, Euan Tubman, et al.
Pageof 10